Replimune Group, Inc. - Common stock, par value $0.001 per share (REPL)

CUSIP: 76029N106

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
82,271,724
Total 13F shares
56,812,005
Share change
+2,217,348
Total reported value
$970,921,194
Put/Call ratio
60%
Price per share
$17.11
Number of holders
126
Value change
+$32,501,979
Number of buys
59
Number of sells
63

Security key

76029N106

Report period

Q3 2023

Institutions

126

Top holders

10

Top shareholders of REPL - Replimune Group, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
7%
5,733,012
$133,121,000 30 Jun 2023
13F
BAKER BROS. ADVISORS LP
13F
Company
5.6%
4,578,280
$106,307,662 30 Jun 2023
13F
Redmile Group, LLC
13F
Company
5.4%
4,420,533
$102,644,776 30 Jun 2023
13F
BlackRock Finance, Inc.
13F
Company
4.2%
3,494,046
$81,131,750 30 Jun 2023
13F
Omega Fund Management, LLC
13F
Company
3.6%
3,001,319
$69,690,627 30 Jun 2023
13F
VANGUARD GROUP INC
13F
Company
2.9%
2,353,899
$54,657,534 30 Jun 2023
13F
BVF INC/IL
13F
Company
2.6%
2,143,036
$49,761,296 30 Jun 2023
13F
Atlas Venture Life Science Advisors, LLC
13F
Company
2.6%
2,098,300
$48,722,526 30 Jun 2023
13F
STATE STREET CORP
13F
Company
2.5%
2,088,981
$48,506,139 30 Jun 2023
13F
Camber Capital Management LP
13F
Company
1.9%
1,550,000
$35,991,000 30 Jun 2023
13F
FMR LLC
13F
Company
1.9%
1,544,568
$35,864,868 30 Jun 2023
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.6%
1,284,449
$29,824,541 30 Jun 2023
13F
MARSHALL WACE, LLP
13F
Company
1.5%
1,233,224
$28,635,461 30 Jun 2023
13F
LOOMIS SAYLES & CO L P
13F
Company
1.4%
1,187,227
$27,567,000 30 Jun 2023
13F
CITADEL ADVISORS LLC
13F
Company
1.4%
1,136,118
$26,380,660 30 Jun 2023
13F
EMERALD ADVISERS, LLC
13F
Company
1.3%
1,086,287
$25,223,584 30 Jun 2023
13F
LORD, ABBETT & CO. LLC
13F
Company
1.3%
1,038,506
$24,114,000 30 Jun 2023
13F
EMERALD MUTUAL FUND ADVISERS TRUST
13F
Company
1.1%
900,952
$20,920,105 30 Jun 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.97%
800,828
$18,595,233 30 Jun 2023
13F
T. Rowe Price Investment Management, Inc.
13F
Company
0.88%
727,610
$16,896,000 30 Jun 2023
13F
MORGAN STANLEY
13F
Company
0.79%
653,565
$15,175,779 30 Jun 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.74%
612,773
$14,228,589 30 Jun 2023
13F
S.c.a. Candriam
13F
Individual
0.74%
612,193
$14,215,122 30 Jun 2023
13F
Artal Group S.A.
13F
Company
0.61%
500,000
$11,610,000 30 Jun 2023
13F
BRAIDWELL LP
13F
Company
0.59%
487,520
$11,320,214 30 Jun 2023
13F
Amundi
13F
Individual
0.55%
452,047
$9,908,870 30 Jun 2023
13F
Integral Health Asset Management, LLC
13F
Company
0.54%
445,000
$10,332,900 30 Jun 2023
13F
NORTHERN TRUST CORP
13F
Company
0.5%
411,842
$9,562,972 30 Jun 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.49%
403,873
$9,377,931 30 Jun 2023
13F
Frazier Life Sciences Management, L.P.
13F
Company
0.47%
386,762
$8,980,614 30 Jun 2023
13F
Sofinnova Investments, Inc.
13F
Company
0.42%
348,889
$8,101,203 30 Jun 2023
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.41%
337,662
$7,840,512 30 Jun 2023
13F
JPMORGAN CHASE & CO
13F
Company
0.37%
302,919
$7,033,779 30 Jun 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.35%
284,946
$6,616,446 30 Jun 2023
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.34%
279,000
$6,478,380 30 Jun 2023
13F
Woodline Partners LP
13F
Company
0.33%
275,001
$6,385,523 30 Jun 2023
13F
Ensign Peak Advisors, Inc
13F
Company
0.33%
270,007
$6,269,563 30 Jun 2023
13F
SECTORAL ASSET MANAGEMENT INC
13F
Company
0.29%
238,541
$5,538,922 30 Jun 2023
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.25%
208,644
$4,844,713 30 Jun 2023
13F
Nuveen Asset Management, LLC
13F
Company
0.24%
194,064
$4,506,167 30 Jun 2023
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.23%
187,627
$4,356,700 30 Jun 2023
13F
Nan Fung Group Holdings Ltd
13F
Company
0.22%
184,739
$4,289,640 30 Jun 2023
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.22%
182,111
$4,228,617 30 Jun 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.22%
178,100
$4,135,000 30 Jun 2023
13F
Bank of New York Mellon Corp
13F
Company
0.2%
168,236
$3,906,440 30 Jun 2023
13F
ExodusPoint Capital Management, LP
13F
Company
0.18%
152,138
$3,533,000 30 Jun 2023
13F
Simplify Asset Management Inc.
13F
Company
0.18%
150,000
$3,483,000 30 Jun 2023
13F
Rafferty Asset Management, LLC
13F
Company
0.18%
144,692
$3,359,748 30 Jun 2023
13F
DEUTSCHE BANK AG\
13F
Company
0.16%
135,434
$3,144,777 30 Jun 2023
13F
TD ASSET MANAGEMENT INC
13F
Company
0.16%
133,823
$3,107,370 30 Jun 2023
13F

Institutional Holders of Replimune Group, Inc. - Common stock, par value $0.001 per share (REPL) as of Q3 2023

As of 30 Sep 2023, Replimune Group, Inc. - Common stock, par value $0.001 per share (REPL) was held by 126 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,812,005 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, Redmile Group, LLC, BlackRock Inc., Omega Fund Management, LLC, VANGUARD GROUP INC, STATE STREET CORP, JANUS HENDERSON GROUP PLC, BVF INC/IL, and Atlas Venture Life Science Advisors, LLC. This page lists 126 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
139
Q3 2023 holders
126
Holder diff
-13
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 Value $ Q3 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .